Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now
Read now
Todd P. Gilmer, Bartolome R. Celli, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Maryam Navaie. (2019) Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 140-151.
Read now
Read now
Donald P Tashkin. (2016) A review of nebulized drug delivery in COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2585-2596.
Read now
Read now
Yaozhu J. Chen, Charles Makin, Vamsi K. Bollu, Maryam Navaie & Bartolome R. Celli. (2016) Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting 2-agonists. Journal of Medical Economics 19:1, pages 11-20.
Read now
Read now
Mark Elphick, Dirk von Hollen, John N Pritchard, Kurt Nikander, Lucy EA Hardaker & Ross HM Hatley. (2015) Factors to consider when selecting a nebulizer for a new inhaled drug product development program. Expert Opinion on Drug Delivery 12:8, pages 1375-1387.
Read now
Read now
Chee H Loh, James F Donohue & Jill A Ohar. (2015) Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease. Expert Opinion on Drug Safety 14:3, pages 463-472.
Read now
Read now
Pamela Spencer & Nicola A Hanania. (2013) Optimizing safety of COPD treatments: role of the nurse practitioner. Journal of Multidisciplinary Healthcare 6, pages 53-63.
Read now
Read now
Rajiv Dhand, Myrna Dolovich, Bradley Chipps, Timothy R. Myers, Ruben Restrepo & Judith Rosen Farrar. (2012) The Role of Nebulized Therapy in the Management of COPD: Evidence and Recommendations. COPD: Journal of Chronic Obstructive Pulmonary Disease 9:1, pages 58-72.
Read now
Read now
James F Donohue & Paul W Jones. (2011) Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 6, pages 35-45.
Read now
Read now
Nicola A. Hanania, James F. Donohue, Harold Nelson, Kenneth Sciarappa, Elizabeth Goodwin, R.A. Baumgartner & J. P. Hanrahan. (2011) The Safety and Efficacy of Arformoterol and Formoterol in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 7:1, pages 17-31.
Read now
Read now
Nicholas J Gross & James F Donohue. (2010) Nebulized formoterol: a review of clinical efficacy and safety in COPD. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 223-232.
Read now
Read now
Mario Cazzola, Nicola A Hanania & Maria G Matera. (2010) Arformoterol tartrate in the treatment of COPD. Expert Review of Respiratory Medicine 4:2, pages 155-162.
Read now
Read now
Paul King. (2008) Role of arformoterol in the management of COPD. International Journal of Chronic Obstructive Pulmonary Disease 3:3, pages 385-392.
Read now
Read now
Articles from other publishers (21)
S.K. Katiyar, S.N. Gaur, R.N. Solanki, Nikhil Sarangdhar, J.C. Suri, Raj Kumar, G.C. Khilnani, Dhruva Chaudhary, Rupak Singla, Parvaiz A. Koul, Ashok A. Mahashur, A.G. Ghoshal, D. Behera, D.J. Christopher, Deepak Talwar, Dhiman Ganguly, H. Paramesh, K.B. Gupta, Mohan Kumar T, P.D. Motiani, P.S. Shankar, Rajesh Chawla, Randeep Guleria, S.K. Jindal, S.K. Luhadia, V.K. Arora, V.K. Vijayan, Abhishek Faye, Aditya Jindal, Amit K. Murar, Anand Jaiswal, Arunachalam M, A.K. Janmeja, Brijesh Prajapat, C. Ravindran, Debajyoti Bhattacharyya, George D'Souza, Inderpaul Singh Sehgal, J.K. Samaria, Jogesh Sarma, Lalit Singh, M.K. Sen, Mahendra K. Bainara, Mansi Gupta, Nilkanth T. Awad, Narayan Mishra, Naveed N. Shah, Neetu Jain, Prasanta R. Mohapatra, Parul Mrigpuri, Pawan Tiwari, R. Narasimhan, R. Vijai Kumar, Rajendra Prasad, Rajesh Swarnakar, Rakesh K. Chawla, Rohit Kumar, S. Chakrabarti, Sandeep Katiyar, Saurabh Mittal, Sonam Spalgais, Subhadeep Saha, Surya Kant, V.K. Singh, Vijay Hadda, Vikas Kumar, Virendra Singh, Vishal Chopra & Visweswaran B. (2022) Indian Guidelines on Nebulization Therapy. Indian Journal of Tuberculosis 69, pages S1-S191.
Crossref
Crossref
Glenn A. Jacobson, Sharanne Raidal, Morten Hostrup, Luigino Calzetta, Richard Wood-Baker, Mark O. Farber, Clive P. Page & E. Haydn Walters. (2018) Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed. Drug Safety 41:5, pages 441-449.
Crossref
Crossref
John N Pritchard & Rachael D Giles. (2014) Opportunities in respiratory drug delivery. Therapeutic Delivery 5:12, pages 1261-1273.
Crossref
Crossref
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharma. (2014) Arformoterol: rationale for use in chronic obstructive pulmonary disease. Clinical Investigation 4:5, pages 429-439.
Crossref
Crossref
Donald A. MahlerLaurie A. WatermanJoseph WardAlex H. Gifford. (2014) Comparison of Dry Powder versus Nebulized Beta-Agonist in Patients with COPD Who Have Suboptimal Peak Inspiratory Flow Rate. Journal of Aerosol Medicine and Pulmonary Drug Delivery 27:2, pages 103-109.
Crossref
Crossref
Kayleigh M Kew, Sofia Dias & Christopher J Cates. (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kayleigh M Kew, Chris Mavergames & Julia AE Walters. (2013)
Long-acting beta
2
-agonists for chronic obstructive pulmonary disease
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Timothy E. Albertson, Michael Schivo, Amir A. Zeki, Samuel Louie, Mark E. Sutter, Mark Avdalovic & Andrew L. Chan. (2013) The Pharmacological Approach to the Elderly COPD Patient. Drugs & Aging 30:7, pages 479-502.
Crossref
Crossref
Matthew C. Miles, James F. Donohue & Jill A. Ohar. (2012) Nebulized arformoterol: what is its place in the management of COPD?. Therapeutic Advances in Respiratory Disease 7:2, pages 81-86.
Crossref
Crossref
Teresa A. Schweiger. (2012) Present and Prospective Therapeutic Regimens for COPD. Clinical Medicine Insights: Therapeutics 4, pages CMT.S2106.
Crossref
Crossref
Jianmiao WANG, Di JIN, Peng ZUO, Tao WANG, Yongjian XU & Weining XIONG. (2011) Comparison of tiotropium plus formoterol to tiotropium alone in stable chronic obstructive pulmonary disease: A meta-analysis. Respirology 16:2, pages 350-358.
Crossref
Crossref
Donald P Tashkin & Leonardo M Fabbri. (2010) Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respiratory Research 11:1.
Crossref
Crossref
Xiaolei Zhang, Laurie A. Waterman, Joseph Ward, John C. Baird & Donald A. Mahler. (2010) Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy. Chest 137:6, pages 1354-1361.
Crossref
Crossref
Shoab A. Nazir & Marcia L. Erbland. (2009) Chronic Obstructive Pulmonary Disease. Drugs & Aging 26:10, pages 813-831.
Crossref
Crossref
Reynold A. PanettieriJr.Jr., Neil MacIntyre, Michael Sims, Edward Kerwin, Charles Fogarty, Michael Noonan, Raymond Claus & William T. Andrews. (2009) Comparison of the efficacy and safety of arformoterol 15 μg twice daily and arformoterol 30 μg once daily in COPD: A single-dose, multicenter, randomized, modified-blind, two-way crossover study. Clinical Therapeutics 31:8, pages 1716-1723.
Crossref
Crossref
Nicola A. Hanania, Ahmad Boota, Edward Kerwin, LaTanya Tomlinson & Kimberly Denis-Mize. (2009) Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide. Drugs 69:9, pages 1205-1216.
Crossref
Crossref
D.P. Tashkin, J.F. Donohue, D.A. Mahler, H. Huang, E. Goodwin, K. Schaefer, J.P. Hanrahan & W.T. Andrews. (2009) Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respiratory Medicine 103:4, pages 516-524.
Crossref
Crossref
Paul T King. (2009) Pharmacotherapy of Chronic Obstructive Pulmonary Disease: Focus on Arformoterol Tartrate. Clinical Medicine. Therapeutics 1, pages CMT.S2584.
Crossref
Crossref
John P. Hanrahan, Donna R. Grogan, Rudolf A. Baumgartner, Amy Wilson, Hailong Cheng, Peter J. Zimetbaum & Joel Morganroth. (2008) Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD). Medicine 87:6, pages 319-328.
Crossref
Crossref
J.F. Donohue, N.A. Hanania, K.A. Sciarappa, E. Goodwin, D.R. Grogan, R.A. Baumgartner & J.P. Hanrahan. (2008) Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: A one year evaluation of safety and tolerance. Therapeutic Advances in Respiratory Disease 2:2, pages 37-48.
Crossref
Crossref
Shridhar Hegde & Michelle Schmidt. 2008.
455
497
.